Huang A, Cao Y, Li B, Xiao J, Zhan SD, Wang NY, Mei XP, Zhao SZ, Han J, Xiao Y, Wang LF, Ma H. Surufatinib achieves radiosensitivity in cholangiocarcinoma by suppressing GINS4 expression to induce Ca2+/cAMP signaling activation. World J Gastroenterol 2026; 32(42): 121690 [DOI: 10.3748/wjg.121690]
Please LOGIN to submit a new comment.